JAK1 Takes a FERM Hold of Type II Cytokine Receptors

Jeffrey J Babon1, Nicholas P D Liau1, Nadia J Kershaw1

  • 1Department of Medical Biology, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC 3052, Australia.

Insights

Janus kinases (JAKs) initiate cytokine signaling by binding to cell receptors. Researchers identified a specific motif used by type II cytokine receptors to recruit JAK1, revealing crucial details of this interaction.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Immunology

Background:

  • Janus kinases (JAKs) are critical intracellular signaling enzymes.
  • JAKs mediate cellular responses to cytokines and interferons.
  • JAKs bind to cytokine receptors near the cell membrane to initiate signaling.

Purpose of the Study:

  • To elucidate the structural basis of JAK-cytokine receptor interactions.
  • To identify the specific molecular interactions involved in recruiting JAK1 to type II cytokine receptors.

Main Methods:

  • X-ray crystallography or cryo-electron microscopy to determine structural details.
  • Biochemical assays to confirm binding interactions.
  • Mutagenesis studies to identify key residues in the recruitment motif.

Main Results:

  • Detailed structural insights into the interaction between type II cytokine receptors and JAK1.
  • Identification of a novel motif responsible for recruiting JAK1 to the receptor.
  • Characterization of the binding interface at an atomic level.

Conclusions:

  • The identified motif is essential for the recruitment of JAK1 by type II cytokine receptors.
  • This structural understanding provides a basis for designing targeted therapies.
  • Advances knowledge of cytokine receptor signaling pathways.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.1K